Quantcast

Copper chelation is a promising new therapy for clogged arteries

Researchers at the Maine Medical Center Research Institute (MMCRI) in Scarborough, Maine, announce their discovery that the renarrowing of arteries following balloon angioplasty can be halted by copper chelation therapy. Preventing the function of copper in the body stops arteries from reclogging following the mechanical stress of removing arterial obstructions through angioplasty. The therapy works by limiting the cellular export of growth factors and cytokines involved in this process.